Executive Director

Description

• Structures terms and negotiates definitive agreements to secure product rights
• Drives the deal process from first contact with potential clients to execution of agreements
• Identifies new opportunities to support Gilead’s businesses (companies, technologies, services, tools, assets, candidates, products)
• Partner with therapeutic area leads and other key personnel to define and execute strategies for acquiring/licensing external assets
• Coordinates the evaluation and diligence of new opportunities across multiple functional areas including Research, Clinical, Regulatory, Commercial, Manufacturing, Finance, Legal, Intellectual Property and other groups
• Independently and in collaboration with internal groups, works to provide detailed economic analyses of new opportunities (e.g., market research, business intelligence, competitive analysis, development plan, commercial forecast, NPV analyses) to inform business decisions
• Presents business rationale, analyses and proposals to senior executives and interface with senior management to reach agreement
• Develops deal concepts and negotiates term sheets and definitive agreements
• Works closely with Gilead’s corporate legal group and finance groups to structure and execute transactions.

Qualifications

• 16+ years of relevant experience in biotech or pharmaceutical companies, including extensive track record of identifying and evaluating deals and executing transactions
• MBA with advanced science degree. In-depth understanding of drug discovery and development process. Experience in inflammation is a plus.
• Excellent communication skills and the ability to influence and work successfully with varied audiences and executives. Deal sheet demonstrating leadership in identifying and evaluating deals, driving business decisions and negotiating complex arrangements.